Arab Finance: October Pharma (OCPH) has reported a net profit after tax of EGP 40.974 million during the first quarter (Q1) of 2022, up from EGP 40.595 million in the same quarter a year earlier, according to financial statements filed to the Egyptian Exchange (EGX) on Monday.
Net sales surged to EGP 179.364 million in Q1 2022, from EGP 165.837 million in Q1 2021.
October Pharma is an Egypt-based company engaged in the production of human pharmaceutical preparations.
The company’s major shareholders include the Arab Company for Drug Industries and Medical Appliances as well as the Saudi-Egyptian Industrial Investment Company.